Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J L Ho

Showing results (11-20 of 63) with videos related to

Pageof 7
Sort By:
Clinical and Diagnostic Laboratory Immunology|November 1, 1994
Rapid culture and quantitation of human immunodeficiency virus type 1 from patient cells without the use of mitogen-stimulated donor cellsP K Kim, S He, J L HO
Journal of Clinical Pharmacology|April 1, 1989
An evaluation of the effect of repeated doses of oral activated charcoal on salicylate eliminationJ L Ho, M G Tierney, G E Dickinson
Bioscience, Biotechnology, and Biochemistry|August 23, 2001
Characterization of the replication region of the Lactobacillus reuteri plasmid pTC82 potentially used in the construction of cloning vectorC F Lin, J L Ho, T C Chung
Journal - Association of Official Analytical Chemists|July 1, 1981
High pressure liquid chromatographic-thermal energy determination of N-nitrosodiethanolamine in cosmeticsJ L Ho, H H Wisneski, R L Yates
The Journal of Experimental Medicine|October 1, 1994
Interleukin 4 receptor signaling in human monocytes and U937 cells involves the activation of a phosphatidylcholine-specific phospholipase C: a comparison with chemotactic peptide, FMLP, phospholipase D, and sphingomyelinaseJ L Ho, B Zhu, S He, et al.
The American Journal of Medicine|January 1, 1984
Hemophilus aphrophilus osteomyelitisJ L Ho, S Soukiasian, W H Oh, et al.
The Journal of Infectious Diseases|July 1, 1990
Granulocyte-macrophage and macrophage colony-stimulating factors activate intramacrophage killing of Leishmania mexicana amazonensisJ L Ho, S G Reed, E A Wick, et al.
The Journal of Infectious Diseases|February 1, 1992
Interleukin-4 inhibits human macrophage activation by tumor necrosis factor, granulocyte-monocyte colony-stimulating factor, and interleukin-3 for antileishmanial activity and oxidative burst capacityJ L Ho, S H He, M J Rios, et al.
Archives of Internal Medicine|March 1, 1986
An outbreak of type 4b Listeria monocytogenes infection involving patients from eight Boston hospitalsJ L Ho, K N Shands, G Friedland, et al.
Biotherapy (Dordrecht, Netherlands)|January 1, 1994
Cytokines in the treatment of leishmaniasis: from studies of immunopathology to patient therapyJ L Ho, R Badaro, D Hatzigeorgiou, et al.
Pageof 7

Showing results (11-20 of 63) with videos related to

Sort By:
Pageof 7
Clinical and Diagnostic Laboratory Immunology|November 1, 1994
Rapid culture and quantitation of human immunodeficiency virus type 1 from patient cells without the use of mitogen-stimulated donor cellsP K Kim, S He, J L HO
Journal of Clinical Pharmacology|April 1, 1989
An evaluation of the effect of repeated doses of oral activated charcoal on salicylate eliminationJ L Ho, M G Tierney, G E Dickinson
Bioscience, Biotechnology, and Biochemistry|August 23, 2001
Characterization of the replication region of the Lactobacillus reuteri plasmid pTC82 potentially used in the construction of cloning vectorC F Lin, J L Ho, T C Chung
Journal - Association of Official Analytical Chemists|July 1, 1981
High pressure liquid chromatographic-thermal energy determination of N-nitrosodiethanolamine in cosmeticsJ L Ho, H H Wisneski, R L Yates
The Journal of Experimental Medicine|October 1, 1994
Interleukin 4 receptor signaling in human monocytes and U937 cells involves the activation of a phosphatidylcholine-specific phospholipase C: a comparison with chemotactic peptide, FMLP, phospholipase D, and sphingomyelinaseJ L Ho, B Zhu, S He, et al.
The American Journal of Medicine|January 1, 1984
Hemophilus aphrophilus osteomyelitisJ L Ho, S Soukiasian, W H Oh, et al.
The Journal of Infectious Diseases|July 1, 1990
Granulocyte-macrophage and macrophage colony-stimulating factors activate intramacrophage killing of Leishmania mexicana amazonensisJ L Ho, S G Reed, E A Wick, et al.
The Journal of Infectious Diseases|February 1, 1992
Interleukin-4 inhibits human macrophage activation by tumor necrosis factor, granulocyte-monocyte colony-stimulating factor, and interleukin-3 for antileishmanial activity and oxidative burst capacityJ L Ho, S H He, M J Rios, et al.
Archives of Internal Medicine|March 1, 1986
An outbreak of type 4b Listeria monocytogenes infection involving patients from eight Boston hospitalsJ L Ho, K N Shands, G Friedland, et al.
Biotherapy (Dordrecht, Netherlands)|January 1, 1994
Cytokines in the treatment of leishmaniasis: from studies of immunopathology to patient therapyJ L Ho, R Badaro, D Hatzigeorgiou, et al.
Pageof 7